Publications by authors named "Ana Stepanovic"

Claim this Profile
S
Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells.
Pavle Stojković, Ema Lupšić, Nataša Terzić Jovanović, Ana Stepanović, Paraskev Nedialkov

Bioorg Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures.
Ana Podolski-Renić, Sofija Jovanović Stojanov, Dragana Marić, Jelena Dinić, Miodrag Dragoj

Curr Issues Mol Biol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma.
Ana Stepanović, Nataša Terzić Jovanović, Aleksandra Korać, Mario Zlatović, Igor Nikolić

Biomed Pharmacother· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors.
Jelena Dinić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells.
Jelena Dinić, Ana Podolski-Renić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović

Diagnostics (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis